共 148 条
[1]
Siegel RL(2021)Cancer statistics, 2021 CA Cancer J Clin 71 7-33
[2]
Miller KD(2015)First-line chemotherapy for mCRC—a review and evidence-based algorithm Nat Rev Clin Oncol 12 607-19
[3]
Fuchs HE(2017)Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer Nat Rev Cancer 17 79-92
[4]
Jemal A(2020)Discovery through clinical sequencing in oncology Nat Cancer 1 774-83
[5]
Cremolini C(2015)PD-1 blockade in tumors with mismatch-repair deficiency N Engl J Med 372 2509-20
[6]
Schirripa M(2017)Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study Lancet Oncol 18 1182-91
[7]
Antoniotti C(2018)Oncogenic signaling pathways in The Cancer Genome Atlas Cell 173 321-37.e10
[8]
Moretto R(2015)Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy Genome Biol 16 2965-70
[9]
Salvatore L(2014)Programmed cell death 1 (PD-1) and its ligand (PD-L1) in common cancers and their correlation with molecular cancer type Cancer Epidemiol Biomark Prev 23 e000881-50.
[10]
Masi G(2020)Somatic POLE exonuclease domain mutations elicit enhanced intratumoral immune responses in stage II colorectal cancer J Immunother Cancer 8 3443-37